+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Toxicology Drug Screening Market by Test Type, Product Type, Sample Type, Drug Class, Application, End User - Global Forecast to 2030- Product Image
Toxicology Drug Screening Market by Test Type, Product Type, Sample Type, Drug Class, Application, End User - Global Forecast to 2030- Product Image
Sale

Toxicology Drug Screening Market by Test Type, Product Type, Sample Type, Drug Class, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 182 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5675244
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The toxicology drug screening market is rapidly transforming as healthcare systems, research organizations, and regulatory bodies worldwide increase scrutiny on substance misuse and drug safety. Decision-makers must swiftly interpret shifting trends and deploy robust solutions to maintain public safety standards, operational efficiency, and strategic positioning.

Market Snapshot: Toxicology Drug Screening Market Growth and Outlook

The global toxicology drug screening market grew from USD 30.59 billion in 2024 to USD 34.82 billion in 2025 and is projected to maintain a 13.47% CAGR, reaching USD 65.31 billion by 2030. This trajectory is driven by increasing demand for rapid, reliable screening platforms across clinical, forensic, workplace, and sports environments, as well as by the need to combat more complex drug misuse patterns globally.

Scope & Segmentation

  • Test Types: Chromatography and Mass Spectrometry (including gas and liquid chromatography-tandem mass spectrometry), Immunoassay, Molecular Diagnostics (next-generation sequencing and PCR-based testing), Rapid Testing.
  • Product Types: Chromatography Systems, Confirmation Services, Consultation Services, Enzyme-Linked Immunosorbent Assay Kits, Lateral Flow Immunoassay Kits, Mass Spectrometers, PCR Instruments, Screening Services.
  • Sample Types: Blood (plasma and whole blood), Hair, Oral Fluid, Saliva, Urine.
  • Drug Classes: Amphetamines, Benzodiazepines, Cannabis, Cocaine, Opiates.
  • Applications: Clinical Diagnostics, Forensic Testing, Pain Management, Sports Anti-Doping, Workplace Testing.
  • End Users: Government and Military Laboratories, Home Care Testing, Hospitals and Clinics, Independent Laboratories, Research Institutes.
  • Regions: Americas (including detailed US states such as California, Texas, New York), Europe, Middle East & Africa (with countries like the United Kingdom, Germany, Saudi Arabia, South Africa), and Asia-Pacific (including China, India, Japan, Australia).
  • Key Companies: Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Agilent Technologies, Inc., Shimadzu Corporation, PerkinElmer, Inc., Waters Corporation, Bio-Rad Laboratories, Inc., Randox Laboratories Ltd.

Key Takeaways

  • Accelerated adoption of high-resolution mass spectrometry and advanced molecular diagnostics is reshaping toxicology testing workflows, meeting rising demands for analytical specificity.
  • Cloud-based data management and AI-driven interpretation tools are streamlining operations and supporting real-time decision-making across both clinical and forensic settings.
  • Expansion of multiplex assay technologies and emergence of point-of-care testing devices are increasing access to rapid and comprehensive drug screening, especially in remote and decentralized environments.
  • Collaboration between instrument manufacturers, genomic companies, and data science vendors is enhancing integrated solutions and service differentiation.
  • End-user requirements vary significantly between sectors such as government labs, hospitals, and independent diagnostics providers, driving diversification of product offerings and support services.
  • Organizations are achieving competitive advantage by building resilient supply chain networks and deploying robust training and support frameworks for end users.

Tariff Impact

The imposition of cumulative United States tariffs on imported drug screening instruments beginning in 2025 has introduced cost pressures for clinical and forensic laboratories. Supply chain adjustments are underway, with organizations seeking tariff-exempt suppliers, investing in domestic manufacturing, and forming group procurement partnerships to manage increased equipment costs. Vendors are responding by revising service contracts and enhancing maintenance offerings to sustain customer relationships amid these changes.

Methodology & Data Sources

This report synthesizes insights from both primary and secondary research. Expert interviews with laboratory directors, procurement leads, and manufacturers combined with targeted surveys validate quantitative trends. Data sources include published peer-reviewed journals, industry white papers, regulatory filings, and proprietary equipment installation databases. All findings are cross-verified and subject to expert review to ensure objectivity and accuracy.

Toxicology Drug Screening Market: Why This Report Matters

  • Enables senior decision-makers to anticipate regulatory shifts, benchmark operational priorities, and pinpoint market segments ripe for investment.
  • Offers clear analysis of current and emerging technologies in drug screening, helping organizations identify pathways to innovation and operational resilience.
  • Provides strategic context for navigating the impact of trade and supply chain disruptions, supporting robust procurement and competitive positioning.

Conclusion

Understanding developments in toxicology drug screening is essential for leaders seeking to navigate risk, enhance compliance, and drive growth. This report equips organizations with actionable intelligence, supporting sustainable decision-making in a complex, evolving market landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Toxicology Drug Screening Market, by Test Type
8.1. Introduction
8.2. Chromatography And Mass Spectrometry
8.2.1. Gas Chromatography-Mass Spectrometry
8.2.2. Liquid Chromatography-Tandem Mass Spectrometry
8.3. Immunoassay
8.4. Molecular Diagnostics
8.4.1. Next-Generation Sequencing
8.4.2. PCR-Based Testing
8.5. Rapid Testing
9. Toxicology Drug Screening Market, by Product Type
9.1. Introduction
9.2. Chromatography Systems
9.3. Confirmation Services
9.4. Consultation Services
9.5. Enzyme-Linked Immunosorbent Assay Kits
9.6. Lateral Flow Immunoassay Kits
9.7. Mass Spectrometers
9.8. PCR Instruments
9.9. Screening Services
10. Toxicology Drug Screening Market, by Sample Type
10.1. Introduction
10.2. Blood
10.2.1. Plasma
10.2.2. Whole Blood
10.3. Hair
10.4. Oral Fluid
10.5. Saliva
10.6. Urine
11. Toxicology Drug Screening Market, by Drug Class
11.1. Introduction
11.2. Amphetamines
11.3. Benzodiazepines
11.4. Cannabis
11.5. Cocaine
11.6. Opiates
12. Toxicology Drug Screening Market, by Application
12.1. Introduction
12.2. Clinical Diagnostics
12.3. Forensic Testing
12.4. Pain Management
12.5. Sports Anti-Doping
12.6. Workplace Testing
13. Toxicology Drug Screening Market, by End User
13.1. Introduction
13.2. Government And Military Laboratories
13.3. Home Care Testing
13.4. Hospitals And Clinics
13.5. Independent Laboratories
13.6. Research Institutes
14. Americas Toxicology Drug Screening Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Toxicology Drug Screening Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Toxicology Drug Screening Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Thermo Fisher Scientific Inc.
17.3.2. Abbott Laboratories
17.3.3. F. Hoffmann-La Roche Ltd.
17.3.4. Siemens Healthineers AG
17.3.5. Agilent Technologies, Inc.
17.3.6. Shimadzu Corporation
17.3.7. PerkinElmer, Inc.
17.3.8. Waters Corporation
17.3.9. Bio-Rad Laboratories, Inc.
17.3.10. Randox Laboratories Ltd
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. TOXICOLOGY DRUG SCREENING MARKET MULTI-CURRENCY
FIGURE 2. TOXICOLOGY DRUG SCREENING MARKET MULTI-LANGUAGE
FIGURE 3. TOXICOLOGY DRUG SCREENING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 14. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. TOXICOLOGY DRUG SCREENING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. TOXICOLOGY DRUG SCREENING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. TOXICOLOGY DRUG SCREENING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PCR-BASED TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY RAPID TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CONFIRMATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CONSULTATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY LATERAL FLOW IMMUNOASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MASS SPECTROMETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PCR INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SCREENING SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PLASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY HAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY ORAL FLUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SALIVA, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY AMPHETAMINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BENZODIAZEPINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CANNABIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COCAINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY OPIATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY FORENSIC TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SPORTS ANTI-DOPING, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY WORKPLACE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY GOVERNMENT AND MILITARY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY HOME CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 73. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 74. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 75. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 76. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 77. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 78. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 79. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 80. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. CANADA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 83. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 84. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 85. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 87. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 88. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 89. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. MEXICO TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 126. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 128. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 129. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 130. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 131. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 133. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 134. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 135. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. GERMANY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 138. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 139. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 140. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 142. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 143. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 144. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. FRANCE TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. ITALY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 156. ITALY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 157. ITALY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 158. ITALY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. ITALY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 160. ITALY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 161. ITALY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 162. ITALY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. ITALY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. SPAIN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 165. SPAIN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 166. SPAIN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 167. SPAIN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 168. SPAIN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 169. SPAIN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 170. SPAIN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 171. SPAIN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. SPAIN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. SAUDI ARABIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 183. SAUDI ARABIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 184. SAUDI ARABIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 185. SAUDI ARABIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 186. SAUDI ARABIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 187. SAUDI ARABIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 188. SAUDI ARABIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 191. SOUTH AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 192. SOUTH AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 193. SOUTH AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 194. SOUTH AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 195. SOUTH AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 196. SOUTH AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. DENMARK TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 201. DENMARK TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 202. DENMARK TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 203. DENMARK TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. DENMARK TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 205. DENMARK TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 206. DENMARK TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 207. DENMARK TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. DENMARK TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. NETHERLANDS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 210. NETHERLANDS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 211. NETHERLANDS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 212. NETHERLANDS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 213. NETHERLANDS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 214. NETHERLANDS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 215. NETHERLANDS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 216. NETHERLANDS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 217. NETHERLANDS TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. QATAR TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 219. QATAR TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 220. QATAR TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 221. QATAR TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 222. QATAR TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 223. QATAR TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 224. QATAR TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 225. QATAR TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. QATAR TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. FINLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 228. FINLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 229. FINLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 230. FINLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 231. FINLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 232. FINLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 233. FINLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 234. FINLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. FINLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 236. SWEDEN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 237. SWEDEN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 238. SWEDEN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 239. SWEDEN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 240. SWEDEN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 241. SWEDEN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 242. SWEDEN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 243. SWEDEN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 244. SWEDEN TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. NIGERIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 246. NIGERIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 247. NIGERIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 248. NIGERIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 249. NIGERIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 250. NIGERIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 251. NIGERIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 252. NIGERIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 253. NIGERIA TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 254. EGYPT TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 255. EGYPT TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 256. EGYPT TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 257. EGYPT TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 258. EGYPT TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 259. EGYPT TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 260. EGYPT TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 261. EGYPT TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. EGYPT TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. TURKEY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 264. TURKEY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 265. TURKEY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 266. TURKEY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. TURKEY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 268. TURKEY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 269. TURKEY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 270. TURKEY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. TURKEY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 272. ISRAEL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 273. ISRAEL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 274. ISRAEL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 275. ISRAEL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 276. ISRAEL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 277. ISRAEL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 278. ISRAEL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 279. ISRAEL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 280. ISRAEL TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 281. NORWAY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 282. NORWAY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 283. NORWAY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 284. NORWAY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 285. NORWAY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 286. NORWAY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 287. NORWAY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 288. NORWAY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 289. NORWAY TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. POLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 291. POLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 292. POLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 293. POLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 294. POLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 295. POLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 296. POLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 297. POLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 298. POLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 303. SWITZERLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 304. SWITZERLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 305. SWITZERLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 306. SWITZERLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 307. SWITZERLAND TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 308. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 309. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY AND MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 310. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 311. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 312. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 313. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY BLOOD, 2018-2030 (USD MILLION)
TABLE 314. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 315. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 316. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 317. ASIA-PACIFIC TOXICOLOGY DRUG SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 318. CHINA TOXICOLOGY DRUG SCR

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Toxicology Drug Screening market report include:
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthineers AG
  • Agilent Technologies, Inc.
  • Shimadzu Corporation
  • PerkinElmer, Inc.
  • Waters Corporation
  • Bio-Rad Laboratories, Inc.
  • Randox Laboratories Ltd

Table Information

Report AttributeDetails
No. of Pages182
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 34.82 Billion
Forecasted Market Value ( USD ) by 2030 $ 65.31 Billion
Compound Annual Growth Rate13.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

In-Vitro Toxicology Testing Market by Service Type, Technology, Application, End User - Global Forecast to 2030 - Product Image

In-Vitro Toxicology Testing Market by Service Type, Technology, Application, End User - Global Forecast to 2030

  • Report
  • 197 Pages
  • Global
From
Neonatal Toxicology - Global Strategic Business Report - Product Image

Neonatal Toxicology - Global Strategic Business Report

  • Report
  • 475 Pages
  • Global
From
ADME Toxicology Testing Market Report by Technology, Product Type, Method, Application, and Region 2024-2032 - Product Image

ADME Toxicology Testing Market Report by Technology, Product Type, Method, Application, and Region 2024-2032

  • Report
  • 145 Pages
  • Global
From
Neonatal Toxicology Market Size, Share & Trends Analysis Report By Specimen (Urine, Umbilical Cord), By Drug (Cannabinoids, Opioids), By Technology, By End Use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Neonatal Toxicology Market Size, Share & Trends Analysis Report By Specimen (Urine, Umbilical Cord), By Drug (Cannabinoids, Opioids), By Technology, By End Use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 150 Pages
  • Global
From
Toxicology Drug Screening - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Toxicology Drug Screening - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 120 Pages
  • Global
From

About the Market

The Toxicology Test market within the context of Diagnostics is a specialized field of testing that focuses on the detection of toxic substances in the body. It is used to identify the presence of drugs, alcohol, and other hazardous substances in the body. Toxicology tests are used to detect the presence of drugs in the body, to monitor drug levels in the body, and to assess the effects of drugs on the body. Toxicology tests are also used to detect the presence of hazardous substances in the environment, such as heavy metals, pesticides, and other pollutants. The Toxicology Test market is a rapidly growing field, with new technologies and methods being developed to improve accuracy and efficiency. Toxicology tests are used in a variety of settings, including clinical laboratories, research laboratories, and public health laboratories. Some companies in the Toxicology Test market include Thermo Fisher Scientific, Abbott Laboratories, Siemens Healthineers, Bio-Rad Laboratories, and Quest Diagnostics. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.